Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

Ana María Henao-Restrepo(World Health Organization - Pakistan), Ira M. Longini(University of Florida), Matthias Egger(University of Bern), Natalie E. Dean(University of Florida), W. John Edmunds(London School of Hygiene & Tropical Medicine), Anton Camacho(London School of Hygiene & Tropical Medicine), Miles W. Carroll(Public Health England), Moussa Doumbia(Centre Pour le Développement des Vaccins-Mali), Bertrand Draguez(Médecins Sans Frontières), Sophie Duraffour(Bernhard Nocht Institute for Tropical Medicine), Godwin Enwere(World Health Organization - Pakistan), Rebecca F. Grais, Stephan Günther(Bernhard Nocht Institute for Tropical Medicine), Stefanie Hossmann(University of Bern), Mandy Kader Kondé, Souleymane Kone(World Health Organization - Pakistan), Eeva Kuisma(Public Health England), Myron M. Levine(University of Maryland, Baltimore), Sema Mandal(Public Health England), Gunnstein Norheim(Norwegian Institute of Public Health), Ximena Riveros(World Health Organization - Pakistan), Aboubacar Soumah, Sven Trelle(University of Bern), Andrea Vicari(World Health Organization - Pakistan), Conall Watson(London School of Hygiene & Tropical Medicine), Sakoba Kéïta(Ministry of Health and Public Hygiene), Marie Paule Kiény(World Health Organization - Pakistan), John-Arne Røttingen(Norwegian Institute of Public Health)
The Lancet
August 1, 2015
Cited by 794Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis